- Home
- BHLB vs NBY Comparison
BHLB vs NBY Comparison
Compare BHLB & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHLB
- NBY
- Stock Information
- Founded
- BHLB 1846
- NBY 2000
- Country
- BHLB United States
- NBY United States
- Employees
- BHLB N/A
- NBY N/A
- Industry
- BHLB Banks
- NBY
- Sector
- BHLB Finance
- NBY
- Exchange
- BHLB Nasdaq
- NBY Nasdaq
- Market Cap
- BHLB N/A
- NBY 3.5M
- IPO Year
- BHLB 2000
- NBY 2007
- Fundamental
- Price
- BHLB $26.23
- NBY $0.68
- Analyst Decision
- BHLB Hold
- NBY
- Analyst Count
- BHLB 5
- NBY 0
- Target Price
- BHLB $25.75
- NBY N/A
- AVG Volume (30 Days)
- BHLB 308.2K
- NBY 7.7M
- Earning Date
- BHLB 10-24-2024
- NBY 11-07-2024
- Dividend Yield
- BHLB 2.74%
- NBY N/A
- EPS Growth
- BHLB N/A
- NBY N/A
- EPS
- BHLB 0.51
- NBY N/A
- Revenue
- BHLB $324,544,000.00
- NBY $13,884,000.00
- Revenue This Year
- BHLB N/A
- NBY N/A
- Revenue Next Year
- BHLB $5.03
- NBY $26.04
- P/E Ratio
- BHLB $51.00
- NBY N/A
- Revenue Growth
- BHLB N/A
- NBY 4.06
- 52 Week Low
- BHLB $18.31
- NBY $0.36
- 52 Week High
- BHLB $28.51
- NBY $14.35
- Technical
- Relative Strength Index (RSI)
- BHLB 47.52
- NBY 51.62
- Support Level
- BHLB $25.45
- NBY $0.64
- Resistance Level
- BHLB $26.50
- NBY $0.75
- Average True Range (ATR)
- BHLB 0.51
- NBY 0.08
- MACD
- BHLB -0.10
- NBY 0.01
- Stochastic Oscillator
- BHLB 33.05
- NBY 14.51
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.